These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32378891)

  • 1. Stalobacin: Discovery of Novel Lipopeptide Antibiotics with Potent Antibacterial Activity against Multidrug-Resistant Bacteria.
    Matsui K; Kan Y; Kikuchi J; Matsushima K; Takemura M; Maki H; Kozono I; Ueda T; Minagawa K
    J Med Chem; 2020 Jun; 63(11):6090-6095. PubMed ID: 32378891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics.
    Domhan C; Uhl P; Meinhardt A; Zimmermann S; Kleist C; Lindner T; Leotta K; Mier W; Wink M
    Int J Antimicrob Agents; 2018 Jul; 52(1):52-62. PubMed ID: 29649587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial Activity of Telavancin Tested
    Duncan LR; Sader HS; Huband MD; Flamm RK; Mendes RE
    Microb Drug Resist; 2020 Aug; 26(8):934-943. PubMed ID: 32049591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short cationic lipopeptides as effective antibacterial agents: Design, physicochemical properties and biological evaluation.
    Azmi F; Elliott AG; Marasini N; Ramu S; Ziora Z; Kavanagh AM; Blaskovich MA; Cooper MA; Skwarczynski M; Toth I
    Bioorg Med Chem; 2016 May; 24(10):2235-41. PubMed ID: 27048775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent Antibiotics Active against Multidrug-Resistant Gram-Negative Bacteria.
    Otsuka Y
    Chem Pharm Bull (Tokyo); 2020; 68(3):182-190. PubMed ID: 32115524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Paenibacillus strain produces a family of linear and cyclic antimicrobial lipopeptides: cyclization is not essential for their antimicrobial activity.
    Huang E; Yang X; Zhang L; Moon SH; Yousef AE
    FEMS Microbiol Lett; 2017 Apr; 364(8):. PubMed ID: 28333237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery, Synthesis, and Optimization of Peptide-Based Antibiotics.
    Hanna CC; Hermant YO; Harris PWR; Brimble MA
    Acc Chem Res; 2021 Apr; 54(8):1878-1890. PubMed ID: 33750106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial efficacy and membrane mechanism of action of the
    Decker T; Rautenbach M; Khan S; Khan W
    Microbiol Spectr; 2024 Jul; 12(7):e0295223. PubMed ID: 38842361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potent antibacterial activity of new short d-enantiomeric lipopeptide against multi drug resistant bacteria.
    Lee J; Kim S; Sim JY; Lee D; Kim HH; Hwang JS; Lee DG; Park ZY; Kim JI
    Biochim Biophys Acta Biomembr; 2019 Jan; 1861(1):34-42. PubMed ID: 30393205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity relationship of novel bisindole amidines active against MDR Gram-positive and Gram-negative bacteria.
    Liu Y; Hu X; Wu Y; Zhang W; Chen X; You X; Hu L
    Eur J Med Chem; 2018 Apr; 150():771-782. PubMed ID: 29604581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2014).
    Duncan LR; Sader HS; Smart JI; Flamm RK; Mendes RE
    J Glob Antimicrob Resist; 2017 Sep; 10():271-276. PubMed ID: 28735051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane-targeting, ultrashort lipopeptide acts as an antibiotic adjuvant and sensitizes MDR gram-negative pathogens toward narrow-spectrum antibiotics.
    Panjla A; Kaul G; Shukla M; Akhir A; Tripathi S; Arora A; Chopra S; Verma S
    Biomed Pharmacother; 2024 Jul; 176():116810. PubMed ID: 38823276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic antimicrobial activity of combinations of sanguinarine and EDTA with vancomycin against multidrug resistant bacteria.
    Hamoud R; Reichling J; Wink M
    Drug Metab Lett; 2014; 8(2):119-28. PubMed ID: 25692301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of telavancin and six comparator agents against anaerobic bacterial isolates.
    Finegold SM; Bolanos M; Sumannen PH; Molitoris DR
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3996-4001. PubMed ID: 19581457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-assembling lipopeptides with a potent activity against Gram-positive bacteria, including multidrug resistant strains.
    Azmi F; Elliott AG; Khalil ZG; Hussein WM; Kavanagh A; Huang JX; Quezada M; Blaskovich MA; Capon RJ; Cooper MA; Skwarczynski M; Toth I
    Nanomedicine (Lond); 2015 Nov; 10(22):3359-71. PubMed ID: 26909416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial and biofilm disruptive nonribosomal lipopeptides from Streptomyces parvulus against multidrug-resistant bacterial infections.
    Kadaikunnan S; Vijayaragavan P; Rathi MA; Balamuralikrishnan B; Alharbi NS; Gopalakrishnan VK; Purushothaman S; Sivanesan R
    J Infect Public Health; 2024 Mar; 17(3):450-456. PubMed ID: 38262082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyathea gigantea (Cyatheaceae) as an antimicrobial agent against multidrug resistant organisms.
    Nath K; Talukdar AD; Bhattacharya MK; Bhowmik D; Chetri S; Choudhury D; Mitra A; Choudhury NA
    BMC Complement Altern Med; 2019 Oct; 19(1):279. PubMed ID: 31640666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octapeptins: Lipopeptide Antibiotics against Multidrug-Resistant Superbugs.
    Abou Fayad A; Herrmann J; Müller R
    Cell Chem Biol; 2018 Apr; 25(4):351-353. PubMed ID: 29677485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dilipid ultrashort cationic lipopeptides as adjuvants for chloramphenicol and other conventional antibiotics against Gram-negative bacteria.
    Domalaon R; Brizuela M; Eisner B; Findlay B; Zhanel GG; Schweizer F
    Amino Acids; 2019 Mar; 51(3):383-393. PubMed ID: 30392097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of telavancin compared with vancomycin and linezolid against Gram-positive organisms isolated from cancer patients.
    Rolston K; Wang W; Nesher L; Coyle E; Shelburne S; Prince RA
    J Antibiot (Tokyo); 2014 Jul; 67(7):505-9. PubMed ID: 24824818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.